Delivery Order SPE2DB24D2205-SPE2DB25FEHYV
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OmniPod 5 DexG7G6 pods (Generation 5) in the amount of $1,426.04, with an ultimate completion date of September 12, 2025. This non-competitive, firm fixed-price delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The order will be fulfilled from...
- The Defense Logistics Agency (DLA) awarded a $2,486.25 delivery order contract to AmerisourceBergen Drug Corp for OmniPod 5 DexG7G6 Pods (Generation 5) on July 29, 2025, with an ultimate completion date of July 30, 2025. This firm fixed price, non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and running through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $28,082.40 to AmerisourceBergen Drug Corp for OmniPod 5 DexG7G6 Pods (Generation 5), 5-unit packages. This competitively awarded, firm fixed-price delivery order, issued on September 19, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The products will be delivered to AmerisourceBergen's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,889.28 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 generation 5 insulin delivery pods, with performance in Conshohocken, Pennsylvania and a completion date of September 17, 2025. This competitively awarded, firm fixed-price delivery order utilizes no set-aside designation and falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a $1,372.91 firm fixed price delivery order to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 generation 5 pods on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, non-set-aside contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under the company's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a $6,381.97 delivery order to AmerisourceBergen Drug Corp for OmniPod 5 DEXG7G6 Pods (Gen 5) 5S, a diabetes management device. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order was placed on July 18, 2025, with an ultimate completion date of July...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $33,926.33 to AmerisourceBergen Drug Corp for OmniPod 5 DEXG7G6 Pods (Generation 5) 5S, medical devices used in diabetes management. The contract, awarded on August 12, 2025, with an ultimate completion date of August 13, 2025, utilizes firm fixed pricing and was awarded on a competitive basis without a set-aside designation. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $50,317.84 firm fixed-price delivery order to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 generation 5 insulin infusion pods. The contract, issued on August 26, 2025, with completion by August 27, 2025, represents a non-competitive delivery order without set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order falls under the company's...
- The Defense Logistics Agency awarded a delivery order valued at $1,102.95 to AmerisourceBergen Drug Corp for OmniPod 5 DEXG7G6 Pods (Generation 5), 5-count units. This competitively awarded, firm fixed-price contract was issued on April 10, 2025, with an ultimate completion date of April 11, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a $7,826.55 firm fixed-price delivery order to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 pods. The contract, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, represents a non-competitive procurement of specialized diabetic medical devices. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and fulfills the delivery order through its corporate office division....
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEHYVDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at approximately $48,000 to AmerisourceBergen Drug Corp for OmniPod 5 DexG7G6 Pods (Generation 5) with a 5-unit configuration. This is a firm fixed price, competitively awarded contract with an ultimate completion date of September 25, 2025. The order will be fulfilled from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. As a child delivery order, this award derives from AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 prime vendor agreement running through December 2026 that supports global pharmaceutical and medical supply needs across the military healthcare system. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor specializing in medical procurement for military and veteran healthcare systems. The company maintains a comprehensive portfolio of federal contracts with the DLA for brand-name and generic medications, vaccines, medical devices, and specialty healthcare commodities across multiple therapeutic domains. The OmniPod 5 delivery order represents a specialized medical device procurement within the broader scope of DLA's pharmaceutical prime vendor operations, which serve customers including the Defense Health Agency and U.S. Coast Guard. This award reflects AmerisourceBergen's established capability to meet federal procurement requirements through competitive contracting and its central role in supporting military medical supply chains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $48.0k | 9/24/25 |